SE389108B - Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan - Google Patents

Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan

Info

Publication number
SE389108B
SE389108B SE7412161A SE7412161A SE389108B SE 389108 B SE389108 B SE 389108B SE 7412161 A SE7412161 A SE 7412161A SE 7412161 A SE7412161 A SE 7412161A SE 389108 B SE389108 B SE 389108B
Authority
SE
Sweden
Prior art keywords
cyclopropylpenylpyrrolidine
derivatives
procedure
preparation
pharmacological effect
Prior art date
Application number
SE7412161A
Other languages
English (en)
Other versions
SE7412161L (sv
Inventor
J-M Teulon
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie filed Critical Hexachimie
Publication of SE7412161L publication Critical patent/SE7412161L/xx
Publication of SE389108B publication Critical patent/SE389108B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7412161A 1973-09-27 1974-09-26 Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan SE389108B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4539573A GB1474907A (en) 1973-09-27 1973-09-27 Pyrolidine derivatives

Publications (2)

Publication Number Publication Date
SE7412161L SE7412161L (sv) 1975-04-01
SE389108B true SE389108B (sv) 1976-10-25

Family

ID=10437065

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7412161A SE389108B (sv) 1973-09-27 1974-09-26 Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan

Country Status (20)

Country Link
US (1) US4005103A (sv)
JP (1) JPS5076052A (sv)
AR (1) AR209281A1 (sv)
AT (1) AT336601B (sv)
BE (1) BE820191A (sv)
CA (1) CA1025456A (sv)
CH (1) CH593255A5 (sv)
CS (1) CS188203B2 (sv)
DD (1) DD114072A5 (sv)
DE (1) DE2446317A1 (sv)
DK (1) DK506474A (sv)
ES (1) ES430394A1 (sv)
FR (1) FR2245361B1 (sv)
GB (1) GB1474907A (sv)
HU (1) HU170007B (sv)
NL (1) NL7412868A (sv)
NO (1) NO743281L (sv)
SE (1) SE389108B (sv)
SU (1) SU544370A3 (sv)
ZA (1) ZA745927B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182729A (en) * 1972-06-22 1980-01-08 Sterling Drug Inc. Arylvinyl cyclopropyl ketones
US4206230A (en) * 1978-11-13 1980-06-03 Mobil Oil Corporation Phenyl cyclopropyl ketone insecticides
AU2002326806B2 (en) * 2001-08-29 2007-07-19 Endo Pharmaceuticals, Inc. Analgetic pyrroline derivatives
US20070129434A1 (en) * 2002-08-29 2007-06-07 Richard Smith-Carliss Analgesics and methods of use
US20060074083A1 (en) * 2004-10-05 2006-04-06 Merz Pharma Gmbh & Co. Kgaa Cyclic and acyclic propenones for treating CNS disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135766A (en) * 1961-10-03 1964-06-02 Mead Johnson & Co 3-substituted-3-pyrrolidinols
US3452015A (en) * 1967-07-12 1969-06-24 Lilly Co Eli Synthesis of beta,beta-alkyl pyrrolidines

Also Published As

Publication number Publication date
DD114072A5 (sv) 1975-07-12
NO743281L (sv) 1975-04-28
CA1025456A (en) 1978-01-31
FR2245361A1 (sv) 1975-04-25
DE2446317A1 (de) 1975-04-10
AU7332474A (en) 1976-03-18
JPS5076052A (sv) 1975-06-21
ES430394A1 (es) 1976-10-16
SE7412161L (sv) 1975-04-01
SU544370A3 (ru) 1977-01-25
ATA765574A (de) 1976-09-15
DK506474A (sv) 1975-06-02
ZA745927B (en) 1975-10-29
AR209281A1 (es) 1977-04-15
GB1474907A (en) 1977-05-25
NL7412868A (nl) 1975-04-02
CH593255A5 (sv) 1977-11-30
US4005103A (en) 1977-01-25
CS188203B2 (en) 1979-02-28
HU170007B (sv) 1977-03-28
BE820191A (fr) 1975-01-16
FR2245361B1 (sv) 1977-11-04
AT336601B (de) 1977-05-10

Similar Documents

Publication Publication Date Title
SE406467B (sv) Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE420604B (sv) Forfarande for framstellning av oxazolderivat
FI55846B (fi) Foerfarande foer framstaellning av 8-azapurin-5-onderivat med terapeutisk anvaendning
SE407575B (sv) Forfarande for framstellning av 1,3-dioxanderivat med terapentisk verkan
SE413244B (sv) Forfarandefor framstellning av bensopyraner med analgetisk verkan
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE404801B (sv) Forfaranden for framstellning av nya tiazolderivat
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE389108B (sv) Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE409206B (sv) Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE417206B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan